| | Abidec / Dalivit | (9.10 Vitamin deficiency) |
| | Acetylcysteine 5% / Hypromellose 0.35% (Ilube) eye drops | (11.8 Miscellaneous ophthalmic preparation) |
| | Adex gel | (13.1 Dry and scaling skin disorders) |
| | Alverine citrate | (1.6 Gastro-intestinal smooth muscle spasm) |
| | Amorolfine 5% nail solution (Loceryl) | (13.2 Infections of the skin) |
| | Aproderm | (13.1 Dry and scaling skin disorders) |
| | AproDerm colloidal oat cream (Paraffin-free) | (13.1 Dry and scaling skin disorders) |
| | Aproderm emollient cream | (13.1 Dry and scaling skin disorders) |
| | Artificial saliva spray (AS Saliva Orthana) | (12.3 Drug acting on the oropharynx) |
| | Azithromycin (oral) | (5.2 Bacterial infection) |
| | Bisacodyl | (1.2 Constipation and bowel cleansing) |
| | Budesonide nasal spray | (12.2 Nose) |
| | Buprenorphine patches | (4.5 Pain) |
| | Calamine lotion | (13.6 Pruritis) |
| | Calcichew (Calcium carbonate) chewable tablet | (9.6 Fluid and electrolyte imbalances) |
| | Calcium 500 (Calcium carbonate) tablet | (9.6 Fluid and electrolyte imbalances) |
| | Calcium carbonate dispersible 250mg tablet & 600mg/5mL suspension | (9.6 Fluid and electrolyte imbalances) |
| | Carbomer 980 gel | (11.8 Miscellaneous ophthalmic preparation) |
| | Carmellose sodium 0.5% or 1% eye drops | (11.8 Miscellaneous ophthalmic preparation) |
| | Cefalexin (oral) | (5.2 Bacterial infection) |
| | Cerazette | (7.3 Contraception) |
| | Cerelle | (7.3 Contraception) |
| | Cetraben ointment | (13.1 Dry and scaling skin disorders) |
| | Cilique | (7.3 Contraception) |
| | Ciprofloxacin (oral) | (5.2 Bacterial infection) |
| | Clindamycin (oral) | (5.2 Bacterial infection) |
| | Clonazepam | (4.5 Pain) |
| | Co-amoxiclav (oral) | (5.2 Bacterial infection) |
| | Co-magaldrox 195/220 suspension (Mucogel - low in sodium) | (1.4 Disorders of gastric acid and ulceration) |
| | Codeine | (4.5 Pain) |
| | Corticosteroids | (4.5 Pain) |
| | Cyanocobalamin | (9.1 Anaemia and some other blood disorders) |
| | Demeclocycline hydrochloride (oral) | (5.2 Bacterial infection) |
| | Depo-Provera (Medroxyprogesterone 150mg vial) | (7.3 Contraception) |
| | Diazepam rectal tubes | (4.1 Epilepsy and other seizure disorders) |
| | Dihydrocodeine (oral) | (4.5 Pain) |
| | Docusate sodium | (1.2 Constipation and bowel cleansing) |
| | Domperidone | (1.4 Disorders of gastric acid and ulceration) |
| | Doublebase Once gel | (13.1 Dry and scaling skin disorders) |
| | Dretine | (7.3 Contraception) |
| | Emollin | (13.1 Dry and scaling skin disorders) |
| | Erythromycin (oral) | (5.2 Bacterial infection) |
| | Esomeprazole granules | (1.4 Disorders of gastric acid and ulceration) |
| | Esomeprazole tablets | (1.4 Disorders of gastric acid and ulceration) |
| | Ethinylestradiol / Norelgestromin patch (Evra) | (7.3 Contraception) |
| | Femodene ED | (7.3 Contraception) |
| | Fentanyl injection | (4.5 Pain) |
| | Fentanyl sublingual tablets | (4.5 Pain) |
| | Ferrous gluconate tablet | (9.1 Anaemia and some other blood disorders) |
| | Fexofenadine | (3.2 Allergic conditions) |
| | Fluocinolone 0.00625% (Synalar 1 in 4) ointment and cream | (13.3 Inflammatory skin conditions) |
| | Fluticasone (inhaled & nebulised) | (3.1 Airways disease, obstructive) |
| | Fluticasone furoate spray (Avamys) | (12.2 Nose) |
| | Forceval | (9.10 Vitamin deficiency) |
| | Fusidic acid 1% viscous eye drops | (11.3 Anti-infective eye preparation) |
| | Gelclair | (12.3 Drug acting on the oropharynx) |
| | Glucagon | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Griseofulvin (oral) | (5.3 Fungal infection) |
| | Haloperidol | (4.4 Nausea and labyrinth disorders) |
| | Hydromorphone | (4.5 Pain) |
| | Hyoscine butyl-bromide | (1.6 Gastro-intestinal smooth muscle spasm) |
| | Itraconazole (oral) | (5.3 Fungal infection) |
| | Ivermectin (oral) | (13.2 Infections of the skin) |
| | Ketoconazole 2% cream (Nizoral) | (13.2 Infections of the skin) |
| | Lansoprazole capsules | (1.4 Disorders of gastric acid and ulceration) |
| | Lansoprazole fastabs | (1.4 Disorders of gastric acid and ulceration) |
| | Levetiracetam intravenous injection | (4.1 Epilepsy and other seizure disorders) |
| | Levomepromazine | (4.4 Nausea and labyrinth disorders) |
| | Lizinna | (7.3 Contraception) |
| | Loperamide liquid / tablets | (1.3 Diarrhoea) |
| | Magnesium glycerophosphate (Neomag) | (9.6 Fluid and electrolyte imbalances) |
| | Magnesium glycerophosphate liquid (unlicensed) | (9.6 Fluid and electrolyte imbalances) |
| | Magnesium oxide (capsules) | (9.6 Fluid and electrolyte imbalances) |
| | Malathion 0.5% liquid | (13.2 Infections of the skin) |
| | Marvelon | (7.3 Contraception) |
| | Mercilon | (7.3 Contraception) |
| | Methadone | (4.5 Pain) |
| | Methylcellulose | (1.2 Constipation and bowel cleansing) |
| | Miconazole 2% cream (Daktarin) | (13.2 Infections of the skin) |
| | Microgynon 30 | (7.3 Contraception) |
| | Microgynon ED | (7.3 Contraception) |
| | Millinette 20/75 | (7.3 Contraception) |
| | Millinette 30/75 | (7.3 Contraception) |
| | Mirena (Levonorgestrel intrauterine device) | (7.3 Contraception) |
| | Naftidrofuryl oxalate | (2.10 Vascular disease) |
| | Nexplanon (Etonogestrel 68mg per rod) | (7.3 Contraception) |
| | Norgeston | (7.3 Contraception) |
| | NovoRapid | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Nystatin cream/ointment (Nystan) | (13.2 Infections of the skin) |
| | Omeprazole 20mg/5ml (4mg/ml) oral suspension sugar free | (1.4 Disorders of gastric acid and ulceration) |
| | Other inhaler | (3.1 Airways disease, obstructive) |
| | Ovranette | (7.3 Contraception) |
| | Oxycodone (oral) | (4.5 Pain) |
| | Permethrin 5% dermal cream | (13.2 Infections of the skin) |
| | Phenazone / lidocaine hydrochloride ear drops solution (Otigo) | (12.1 Ear) |
| | Pilocarpine tablets | (12.3 Drug acting on the oropharynx) |
| | Potassium hydroxide solution 5% (MolluDab) | (13.2 Infections of the skin) |
| | Promethazine | (3.2 Allergic conditions) |
| | Pyridoxine | (4.1 Epilepsy and other seizure disorders) |
| | QV lotion | (13.1 Dry and scaling skin disorders) |
| | Renavit | (9.10 Vitamin deficiency) |
| | Salbutamol (parenteral) | (3.1 Airways disease, obstructive) |
| | Saliva replacement gel (Biotene Oralbalance) | (12.3 Drug acting on the oropharynx) |
| | Salivix pastilles | (12.3 Drug acting on the oropharynx) |
| | Slynd | (7.3 Contraception) |
| | Sodium citrate | (1.4 Disorders of gastric acid and ulceration) |
| | Sodium hyaluronate (0.2%) | (11.8 Miscellaneous ophthalmic preparation) |
| | Sodium picosulfate | (1.2 Constipation and bowel cleansing) |
| | Sterculia / Frangula (Normacol plus) | (1.2 Constipation and bowel cleansing) |
| | Synalar (Fluocinolone 0.025%) gel / ointment / cream | (13.3 Inflammatory skin conditions) |
| | Terbutaline (inhaled & nebulised) | (3.1 Airways disease, obstructive) |
| | Tetracycline (oral) | (5.2 Bacterial infection) |
| | Tolbutamide | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Tuberculin PPD RT 23 SSI, 10 T.U./0.1mL | (14.3 Tuberculosis diagnostic test) |
| | Ulipristal (EllaOne) | (7.3 Contraception) |
| | Ultraveen | (13.1 Dry and scaling skin disorders) |
| | Vancomycin (oral) | (5.2 Bacterial infection) |
| | Yacella | (7.3 Contraception) |
| | Acetazolamide 250mg tablets | (2.8 Oedema) |
Needed
|
| | Acetazolamide | (4.1 Epilepsy and other seizure disorders) |
|
| | Aciclovir 3% eye ointment | (11.3 Anti-infective eye preparation) |
Specialist Recommended
|
| | Alfacalcidol capsules / drops | (9.10 Vitamin deficiency) |
Specialist Recommended
|
| | Amiloride | (2.8 Oedema) |
Needed
|
| | Amiodarone (oral) | (2.1 Arrhythmias) |
|
| | Amitriptyline | (4.2 Mental health disorders) |
|
| | Amitriptyline | (4.5 Pain) |
|
| | Amlodipine | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Arginine | (9.7 Metabolic disorders) |
3 month
|
| | Aripiprazole (oral) | (4.2 Mental health disorders) |
3 month
|
| | Asacol modified-release tablets / suppositories | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Aspirin | (2.3 Blood clots) |
Specialist Initiated
|
| | Atenolol | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Atorvastatin | (2.6 Hyperlipidaemia) |
Specialist Initiated
|
| | Atropine 1% eye drops | (11.5 Mydriatics and cycloplegic) |
|
| | Azathioprine IBD BRHC | (1.1 Chronic bowel disorders) |
1 month
|
| | Azithromycin 1.5% eye drops | (11.3 Anti-infective eye preparation) |
|
| | Baclofen | (4.3 Movement disorders) |
|
| | Bendroflumethiazide 2.5mg tablets | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Betamethasone (parenteral) | (6.2 Corticosteroid responsive conditions) |
Specialist Recommended
|
| | Betamethasone 0.1% eye drops | (11.4 Corticosteroid and other anti-inflammatory preparations) |
Specialist Recommended
|
| | Bezafibrate | (2.6 Hyperlipidaemia) |
Specialist Initiated
|
| | Brivaracetam | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Budesonide nebules | (1.4 Disorders of gastric acid and ulceration) |
3 month
|
| | Budesonide orodispersible tablets (Jorveza) | (1.4 Disorders of gastric acid and ulceration) |
3 month
|
| | Bupropion hydrochloride | (4.7 Substance dependence) |
|
| | Calcium folinate (folinic acid) | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
Specialist Recommended
|
| | Captopril | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Carbamazepine | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Carbamazepine | (4.5 Pain) |
|
| | Carbimazole | (6.8 Thyroid disorders) |
Specialist Recommended
|
| | Carvedilol | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Cetirizine | (1.5 Food Allergy) |
Specialist Recommended
|
| | Chloral hydrate | (4.3 Movement disorders) |
|
| | Chlorothiazide | (2.4 Blood pressure conditions) |
Specialist Recommended
|
| | Chlorothiazide | (2.8 Oedema) |
Needed
|
| | Ciclosporin 1mg/mL eye drops (Verkazia) | (11.8 Miscellaneous ophthalmic preparation) |
Specialist Recommended
|
| | Citalopram | (4.2 Mental health disorders) |
Specialist Recommended
|
| | Citramag | (1.2 Constipation and bowel cleansing) |
Specialist Recommended
|
| | Citrulline | (9.7 Metabolic disorders) |
3 month
|
| | Clobazam | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Clobetasol propionate 0.05% / Neomycin sulphate 0.5% / Nystatin 100,000 units/g cream / ointment | (13.3 Inflammatory skin conditions) |
Specialist Recommended
|
| | Clobetasol propionate 0.05% cream / ointment (Dermovate) | (13.3 Inflammatory skin conditions) |
Specialist Recommended
|
| | Clonazepam | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Clonidine | (4.3 Movement disorders) |
|
| | Co-careldopa (Sinemet) | (4.3 Movement disorders) |
|
| | Colestyramine | (1.3 Diarrhoea) |
Specialist Recommended
|
| | Colestyramine | (2.6 Hyperlipidaemia) |
Specialist Initiated
|
| | Creon Micro (graunles) | (1.10 Reduced exocrine secretions) |
Specialist Initiated
|
| | Cyclopentolate 0.5 % or 1% eye drops | (11.5 Mydriatics and cycloplegic) |
3 month
|
| | Dexamethasone 0.1% eye drops (brands include Maxidex) | (11.4 Corticosteroid and other anti-inflammatory preparations) |
Specialist Recommended
|
| | Dexamethasone | (4.4 Nausea and labyrinth disorders) |
|
| | Diazepam | (4.3 Movement disorders) |
|
| | Diclofenac | (10.3 Pain and inflammation in musculoskeletal disorders) |
Specialist Recommended
|
| | Digoxin (oral) | (2.1 Arrhythmias) |
Specialist Initiated
|
| | Diltiazem immediate and modified-release | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Enalapril | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Eslicarbazepine | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Ethosuximide | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Etoricoxib | (10.3 Pain and inflammation in musculoskeletal disorders) |
Specialist Recommended
|
| | Ezetimibe | (2.6 Hyperlipidaemia) |
Specialist Initiated
|
| | Fenofibrate (micronised or modified-release) | (2.6 Hyperlipidaemia) |
Specialist Initiated
|
| | Flecainide (oral) | (2.1 Arrhythmias) |
Specialist Initiated
|
| | Fludrocortisone - mineralocorticoid (oral) | (6.2 Corticosteroid responsive conditions) |
Specialist Recommended
|
| | Fluorometholone 0.1% eye drops | (11.4 Corticosteroid and other anti-inflammatory preparations) |
|
| | Fluoxetine | (4.2 Mental health disorders) |
Specialist Recommended
|
| | Fluvoxamine | (4.2 Mental health disorders) |
|
| | Furosemide | (2.5 Heart Failure) |
Specialist Initiated
|
| | Furosemide | (2.8 Oedema) |
Specialist Initiated
|
| | Gabapentin | (4.1 Epilepsy and other seizure disorders) |
|
| | Gabapentin | (4.3 Movement disorders) |
|
| | Gabapentin | (4.5 Pain) |
|
| | Glyceryl trinitrate 4mg/mL (unlicensed) | (1.9 Rectal and anal disorders) |
Specialist Recommended
|
| | Glycopyrronium bromide (Sialanar) | (12.3 Drug acting on the oropharynx) |
3 month
|
| | Guanfacine modified-release tablets | (4.2 Mental health disorders) |
3 month
|
| | Haloperidol | (4.2 Mental health disorders) |
|
| | Haloperidol | (4.3 Movement disorders) |
|
| | Hepatitis B vaccine (HBvaxPRO 40microgram, Engerix B) | (14.4 Vaccines) |
Specialist Recommended
|
| | Hydrocortisone - glucocorticoid (oral) | (6.2 Corticosteroid responsive conditions) |
Specialist Recommended
|
| | Hydrocortisone (Alkindi) | (6.2 Corticosteroid responsive conditions) |
Specialist Recommended
|
| | Hydrocortisone (Efmody) | (6.2 Corticosteroid responsive conditions) |
Specialist Recommended
|
| | Hydrocortisone (parenteral) | (6.2 Corticosteroid responsive conditions) |
Specialist Recommended
|
| | Hydroxocobalamin intramuscular injection | (9.1 Anaemia and some other blood disorders) |
|
| | Hyoscine hydrobromide patch | (4.4 Nausea and labyrinth disorders) |
Specialist Recommended
|
| | Hypertonic Sodium chloride 6% (Mucoclear) or 7% (Nebusal) | (3.3 Conditions affecting sputum viscosity) |
|
| | Indometacin | (10.3 Pain and inflammation in musculoskeletal disorders) |
Specialist Recommended
|
| | Insulin Fiasp | (6.3 Diabetes mellitus and hypoglycaemia) |
Specialist Recommended
|
| | Irbesartan | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Ispaghula husk (Fybogel) | (1.2 Constipation and bowel cleansing) |
Specialist Recommended
|
| | Ketotifen | (1.5 Food Allergy) |
Specialist Recommended
|
| | Lacosamide | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Lamotrigine | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Lamotrigine | (4.5 Pain) |
|
| | Levetiracetam | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Levothyroxine | (6.8 Thyroid disorders) |
Specialist Recommended
|
| | Lisdexamfetamine | (4.2 Mental health disorders) |
3 month
|
| | Lisinopril | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Lorazepam | (4.4 Nausea and labyrinth disorders) |
|
| | Losartan | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Loteprednol 0.5% eye drops | (11.4 Corticosteroid and other anti-inflammatory preparations) |
1 month
|
| | Mefenamic acid | (10.3 Pain and inflammation in musculoskeletal disorders) |
Specialist Recommended
|
| | Melatonin modified-release and immediate-release | (4.6 Sleep disorders) |
3 month
|
| | Mercaptopurine IBD BRHC | (1.1 Chronic bowel disorders) |
1 month
|
| | Mesalazine modified-release (Octasa) | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Methotrexate IBD | (1.1 Chronic bowel disorders) |
1 month
|
| | Methotrexate | (10.1 Arthritis) |
1 month
|
| | Methotrexate | (13.3 Inflammatory skin conditions) |
1 month
|
| | Methylphenidate immediate-release & modified-release | (4.2 Mental health disorders) |
3 month
|
| | Methylprednisolone (parenteral) | (6.2 Corticosteroid responsive conditions) |
Specialist Recommended
|
| | Metoprolol | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Mezavant XL | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Midazolam | (4.3 Movement disorders) |
|
| | Mirabegron | (7.1 Bladder and urinary disorders) |
3 month
|
| | Morphine | (15.1 General Anaesthesia) |
|
| | Morphine | (4.5 Pain) |
Specialist Recommended
|
| | Moviprep | (1.2 Constipation and bowel cleansing) |
Specialist Recommended
|
| | Nadolol | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Naproxen | (10.3 Pain and inflammation in musculoskeletal disorders) |
Specialist Recommended
|
| | Nifedipine capsules non modified-release | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Nortriptyline | (4.5 Pain) |
|
| | Nutrizym 22 Capsules | (1.10 Reduced exocrine secretions) |
Specialist Initiated
|
| | Ondansetron | (4.4 Nausea and labyrinth disorders) |
Specialist Recommended
|
| | Oxcarbazepine | (4.1 Epilepsy and other seizure disorders) |
|
| | Oxybutynin modified-release | (7.1 Bladder and urinary disorders) |
Specialist Recommended
|
| | Oxybutynin standard-release | (7.1 Bladder and urinary disorders) |
Specialist Recommended
|
| | Oxycodone | (15.1 General Anaesthesia) |
|
| | Pancrex V Capsules | (1.10 Reduced exocrine secretions) |
Specialist Initiated
|
| | Paravit | (9.10 Vitamin deficiency) |
Specialist Recommended
|
| | Pentasa tablets / modified-release granules | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Perampanel | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Phenobarbital (oral) | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Phenylephrine 2.5% eye drops / single-use eye drops | (11.5 Mydriatics and cycloplegic) |
|
| | Phenytoin (oral) | (4.1 Epilepsy and other seizure disorders) |
|
| | Picolax | (1.2 Constipation and bowel cleansing) |
Specialist Recommended
|
| | Pimecrolimus 1% cream (Elidel) | (13.3 Inflammatory skin conditions) |
|
| | Potassium Chloride 600mg (8mmol) modified release tablets | (9.6 Fluid and electrolyte imbalances) |
Specialist Recommended
|
| | Potassium citrate mixture BP (1mL solution = 2.8 mmol/K+ = 2.8 mmol/Bicarbonate = 0.9mmol/citrate) | (9.6 Fluid and electrolyte imbalances) |
|
| | Pravastatin | (2.6 Hyperlipidaemia) |
Specialist Initiated
|
| | Prednisolone 0.5% eye drops (brands include Predsol) | (11.4 Corticosteroid and other anti-inflammatory preparations) |
Specialist Recommended
|
| | Prednisolone 1% eye drops (brands include Pred Forte) | (11.4 Corticosteroid and other anti-inflammatory preparations) |
|
| | Prednisolone rectal aerosol (Predfoam) | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Prednisolone retention enema | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Prednisolone suppository | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Prednisolone | (10.4 Soft tissue and joint disorders) |
Specialist Recommended
|
| | Prednisolone | (4.1 Epilepsy and other seizure disorders) |
|
| | Pregabalin | (4.1 Epilepsy and other seizure disorders) |
1 month
|
| | Pregabalin | (4.5 Pain) |
|
| | Primidone | (4.1 Epilepsy and other seizure disorders) |
|
| | Procyclidine | (4.3 Movement disorders) |
|
| | Propranolol | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Propranolol | (4.5 Pain) |
|
| | Qlaira (estradiol valerate / dienogest) | (7.3 Contraception) |
Specialist Recommended
|
| | Riboflavin (oral) | (9.10 Vitamin deficiency) |
|
| | Riboflavin | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
3 month
|
| | Rifampicin (oral) | (5.2 Bacterial infection) |
Specialist Recommended
|
| | Risperidone | (4.2 Mental health disorders) |
|
| | Rosuvastatin | (2.6 Hyperlipidaemia) |
Specialist Initiated
|
| | Rufinamide | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Salofalk retention enema / suppositories / granules / foam enema | (1.1 Chronic bowel disorders) |
Specialist Recommended
|
| | Sertraline | (4.2 Mental health disorders) |
Specialist Recommended
|
| | Silicone Gel | (13.9 Miscellaneous skin preparations) |
Specialist Recommended
|
| | Simvastatin | (2.6 Hyperlipidaemia) |
Specialist Initiated
|
| | Sodium benzoate | (9.7 Metabolic disorders) |
3 month
|
| | Sodium bicarbonate 500mg capsules | (9.6 Fluid and electrolyte imbalances) |
|
| | Sodium bicarbonate 8.4% (1mmol/mL) oral liquid | (9.6 Fluid and electrolyte imbalances) |
|
| | Sodium bicarbonate 8.4% injection / infusion | (9.6 Fluid and electrolyte imbalances) |
|
| | Sodium chloride 0.45% / Glucose 2.5% intravenous infusion | (9.6 Fluid and electrolyte imbalances) |
|
| | Sodium chloride 0.45% / Glucose 5% intravenous infusion | (9.6 Fluid and electrolyte imbalances) |
|
| | Sodium citrate enema | (1.2 Constipation and bowel cleansing) |
Specialist Recommended
|
| | Sodium cromoglicate | (1.5 Food Allergy) |
Specialist Recommended
|
| | Solifenacin | (7.1 Bladder and urinary disorders) |
Specialist Recommended
|
| | Sotalol (oral) | (2.1 Arrhythmias) |
|
| | Spironolactone (oral) | (13.7 Rosacea and Acne) |
Specialist Initiated
|
| | Spironolactone | (2.5 Heart Failure) |
Specialist Initiated
|
| | Stiripentol | (4.1 Epilepsy and other seizure disorders) |
|
| | Sulfasalazine | (1.1 Chronic bowel disorders) |
3 month
|
| | Sumatriptan (subcutaneous injection) | (4.5 Pain) |
|
| | Tacrolimus 0.1% ointment (Protopic) | (13.3 Inflammatory skin conditions) |
Specialist Recommended
|
| | Testosterone (oral) | (6.7 Sex hormone responsive conditions) |
1 month
|
| | Testosterone gel (Testogel, Testim, Tostran gel) | (6.7 Sex hormone responsive conditions) |
Specialist Recommended
|
| | Testosterone oily injection (Nebido) | (6.7 Sex hormone responsive conditions) |
Specialist Recommended
|
| | Testosterone oily injection (Sustanon 250) | (6.7 Sex hormone responsive conditions) |
Specialist Recommended
|
| | Tetracosactide | (4.1 Epilepsy and other seizure disorders) |
|
| | Theophylline modified-release | (3.1 Airways disease, obstructive) |
Specialist Recommended
|
| | Tiagabine | (4.1 Epilepsy and other seizure disorders) |
|
| | Tolterodine (standard-release & modified-release) | (7.1 Bladder and urinary disorders) |
Specialist Recommended
|
| | Topiramate | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Tramadol | (4.5 Pain) |
Specialist Recommended
|
| | Tramadol | (15.1 General Anaesthesia) |
|
| | Tramadol | (4.5 Pain) |
|
| | Tresiba | (6.3 Diabetes mellitus and hypoglycaemia) |
3 month
|
| | Trihexyphenidyl | (4.3 Movement disorders) |
|
| | Tropicamide 0.5% or 1% single-use eye drops | (11.5 Mydriatics and cycloplegic) |
|
| | Ubidecarenone (Co-enzyme Q10) | (9.7 Metabolic disorders) |
3 month
|
| | Ursodeoxycholic acid | (1.7 Liver disorders and related conditions) |
Specialist Recommended
|
| | Varenicline | (4.7 Substance dependence) |
|
| | Verapamil (oral) | (2.1 Arrhythmias) |
|
| | Verapamil immediate and modified-release | (2.4 Blood pressure conditions) |
Specialist Initiated
|
| | Vitamin A+D | (9.10 Vitamin deficiency) |
Specialist Recommended
|
| | Vitamin A | (9.10 Vitamin deficiency) |
Specialist Recommended
|
| | Warfarin | (2.3 Blood clots) |
Specialist Initiated
|
| | Zinc acetate | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
3 month
|
| | Zolmitriptan | (4.5 Pain) |
|
| | Zonisamide | (4.1 Epilepsy and other seizure disorders) |
3 month
|
| | Abacavir (oral) | (5.6 Viral infection) |
| | Abacavir / Dolutegravir / Lamivudine (oral) | (5.6 Viral infection) |
| | Abatacept | (10.1 Arthritis) |
| | Abrocitinib (oral) | (13.3 Inflammatory skin conditions) |
| | Acarizax (oral) | (3.2 Allergic conditions) |
| | Acetylcysteine 10% eye drops (unlicensed) | (11.8 Miscellaneous ophthalmic preparation) |
| | Aciclovir (parenteral) | (5.6 Viral infection) |
| | Acitretin | (13.3 Inflammatory skin conditions) |
| | Adalimumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Adalimumab | (1.1 Chronic bowel disorders) |
| | Adalimumab | (10.1 Arthritis) |
| | Adenosine | (2.1 Arrhythmias) |
| | Adrenaline (epinephrine) 1 in 10,000 (100micrograms/mL) only in secondary care | (2.4 Blood pressure conditions) |
| | Adrenaline | (2.5 Heart Failure) |
| | Aflibercept | (11.8 Miscellaneous ophthalmic preparation) |
| | Agalsidase alfa & beta | (9.7 Metabolic disorders) |
| | Ajmaline (Unlicensed) | (2.1 Arrhythmias) |
| | Albendazole (oral) (unlicensed) | (5.4 Helminth infection) |
| | Alemtuzumab (parenteral) | (8.1 Immune system) |
| | Alfacalcidol (parenteral) | (9.10 Vitamin deficiency) |
| | Alfentanil injection | (4.5 Pain) |
| | Alfentanil intranasal | (4.5 Pain) |
| | Alfentanil | (15.1 General Anaesthesia) |
| | Alglucosidase alfa | (9.7 Metabolic disorders) |
| | Alitretinoin | (13.3 Inflammatory skin conditions) |
| | Alprostadil | (2.9 Patent ductus arteriosus) |
| | Alteplase | (2.3 Blood clots) |
| | Alteplase | (2.7 Myocardial ischaemia) |
| | Alutard | (3.2 Allergic conditions) |
| | Amikacin (parenteral) | (5.2 Bacterial infection) |
| | Amikacin 35mg/mL (unlicensed) | (11.3 Anti-infective eye preparation) |
| | Aminophylline (intravenous) | (3.1 Airways disease, obstructive) |
| | Amiodarone (intravenous) | (2.1 Arrhythmias) |
| | Amisulpride | (4.2 Mental health disorders) |
| | Amoxicillin (parenteral) | (5.2 Bacterial infection) |
| | Amphotericin 0.15% eye drops (unlicensed Special) | (11.3 Anti-infective eye preparation) |
| | Anagrelide (oral) | (9.4 Platelet disorders) |
| | Anakinra | (8.1 Immune system) |
| | Anti-D (Rho) immunoglobulin | (14.1 Immunoglobulin Therapy) |
| | Antithymocyte globulin (ATG) (horse) | (8.1 Immune system) |
| | Antithymocyte globulin (ATG) (rabbit) | (8.1 Immune system) |
| | Apraclonidine 1% eye drops | (11.8 Miscellaneous ophthalmic preparation) |
| | Aprepitant | (4.4 Nausea and labyrinth disorders) |
| | Arachis oil enema | (1.2 Constipation and bowel cleansing) |
| | Arginine | (6.6 Hypothalamic and anterior pituitary hormone related disorders) |
| | Aripiprazole (oral) | (4.2 Mental health disorders) |
| | Artemether / Lumefantrine (oral) (Riamet) | (5.5 Protozoal infection) |
| | Asfotase alfa | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Ataluren | (4.3 Movement disorders) |
| | Atazanavir (oral) | (5.6 Viral infection) |
| | Atovaquone (oral) | (5.3 Fungal infection) |
| | Atracurium | (15.1 General Anaesthesia) |
| | Azacitidine (parenteral) | (8.1 Immune system) |
| | Azathioprine (oral & parenteral) | (8.1 Immune system) |
| | Azathioprine (oral) | (13.3 Inflammatory skin conditions) |
| | Azathioprine | (10.1 Arthritis) |
| | Aztreonam (nebulised) | (5.2 Bacterial infection) |
| | Baclofen (intrathecal) | (10.2 Neuromuscular disorders) |
| | Baricitinib | (10.1 Arthritis) |
| | Basiliximab (parenteral) | (8.1 Immune system) |
| | Bendamustine | (8.2 Malignant disease) |
| | Benzylpenicillin sodium (parenteral) | (5.2 Bacterial infection) |
| | Beractant (Survanta) | (3.5 Respiratory depression, respiratory distress syndrome and apnoea) |
| | Betaine - named patient, specialist use only | (9.7 Metabolic disorders) |
| | Bevacizumab | (11.8 Miscellaneous ophthalmic preparation) |
| | Biotin | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Bleomycin (parenteral) | (8.2 Malignant disease) |
| | Bosentan (oral) | (2.4 Blood pressure conditions) |
| | Botulinum toxin type A (Botox, Dysport, Xeomin) | (4.3 Movement disorders) |
| | Botulinum toxin type A (Botox) | (4.5 Pain) |
| | Botulinum toxin type A | (12.3 Drug acting on the oropharynx) |
| | Botulinum toxin type A | (7.1 Bladder and urinary disorders) |
| | Botulinum toxin type B (Neurobloc) | (4.3 Movement disorders) |
| | Botulism antitoxin | (14.2 Post-exposure prophylaxis) |
| | Budesonide (oral) (Budenofalk) | (1.1 Chronic bowel disorders) |
| | Bumetanide | (2.5 Heart Failure) |
| | Bumetanide | (2.8 Oedema) |
| | Bupivacaine 0.1% / Fentanyl 2micrograms/mL epidural | (15.2 Local Anaesthesia) |
| | Bupivacaine 0.1% for epidural infusion | (15.2 Local Anaesthesia) |
| | Burosumab | (6.4 Drugs affecting bone metabolism) |
| | Busulfan (Busulphan) (oral & parenteral) | (8.2 Malignant disease) |
| | C1-esterase inhibitor | (3.2 Allergic conditions) |
| | Caffeine | (3.5 Respiratory depression, respiratory distress syndrome and apnoea) |
| | Calcitonin salmon (salcatonin) injection | (6.4 Drugs affecting bone metabolism) |
| | Calcitriol (parenteral) | (9.10 Vitamin deficiency) |
| | Calcium gluconate 10% 2.2mmols/10mL (parenteral) | (9.6 Fluid and electrolyte imbalances) |
| | Canakinumab | (8.1 Immune system) |
| | Cannabidiol (Epidyolex) | (4.1 Epilepsy and other seizure disorders) |
| | Carboplatin (parenteral) | (8.2 Malignant disease) |
| | Carglumic acid | (9.7 Metabolic disorders) |
| | Caspofungin (parenteral) | (5.3 Fungal infection) |
| | Cefaclor (oral) | (5.2 Bacterial infection) |
| | Cefadroxil (oral) | (5.2 Bacterial infection) |
| | Cefazolin (parenteral) | (5.2 Bacterial infection) |
| | Cefixime (oral) | (5.2 Bacterial infection) |
| | Cefotaxime (oral) | (5.2 Bacterial infection) |
| | Cefoxitin (parenteral) (unlicensed) | (5.2 Bacterial infection) |
| | Cefradine (oral) | (5.2 Bacterial infection) |
| | Ceftazidime (parenteral) | (5.2 Bacterial infection) |
| | Ceftriaxone (parenteral) | (5.2 Bacterial infection) |
| | Cefuroxime (parenteral) | (5.2 Bacterial infection) |
| | Cefuroxime 5% eye drops (unlicensed) | (11.3 Anti-infective eye preparation) |
| | Chenodeoxycholic acid | (1.7 Liver disorders and related conditions) |
| | Chloral hydrate | (4.6 Sleep disorders) |
| | Chlorambucil (oral) | (8.2 Malignant disease) |
| | Chloramphenicol (oral & parenteral) | (5.2 Bacterial infection) |
| | Chlorhexidine 0.02% eye drops (unlicensed) | (11.3 Anti-infective eye preparation) |
| | Chlorhexidine 0.2% eye drops (unlicensed) | (11.3 Anti-infective eye preparation) |
| | Chloroquine (oral) | (5.5 Protozoal infection) |
| | Cholesterol | (1.7 Liver disorders and related conditions) |
| | Cholic acid | (1.7 Liver disorders and related conditions) |
| | Chorionic gonadotropin (HCG) | (6.7 Sex hormone responsive conditions) |
| | Ciclosporin (oral & parenteral) | (8.1 Immune system) |
| | Ciclosporin (oral) | (13.3 Inflammatory skin conditions) |
| | Ciclosporin 0.2% eye ointment (unlicensed) | (11.8 Miscellaneous ophthalmic preparation) |
| | Ciclosporin 1mg/mL eye drops | (11.8 Miscellaneous ophthalmic preparation) |
| | Ciclosporin | (1.1 Chronic bowel disorders) |
| | Ciclosporin | (10.1 Arthritis) |
| | Cidofovir (parenteral) | (5.6 Viral infection) |
| | Cinacalcet | (6.8 Thyroid disorders) |
| | Cinacalcet | (9.6 Fluid and electrolyte imbalances) |
| | Ciprofloxacin (parenteral) | (5.2 Bacterial infection) |
| | Cisplatin (parenteral) | (8.2 Malignant disease) |
| | Clarithromycin (parenteral) | (5.2 Bacterial infection) |
| | Clindamycin (parenteral) | (5.2 Bacterial infection) |
| | Clindamycin | (5.5 Protozoal infection) |
| | Clomethiazole | (4.1 Epilepsy and other seizure disorders) |
| | Clonidine patches | (4.3 Movement disorders) |
| | Clonidine | (2.4 Blood pressure conditions) |
| | Clopidogrel | (2.3 Blood clots) |
| | Clozapine | (4.2 Mental health disorders) |
| | CMV immunoglobulin | (14.1 Immunoglobulin Therapy) |
| | Co-amoxiclav (parenteral) | (5.2 Bacterial infection) |
| | Co-trimoxazole (oral & parenteral) | (5.2 Bacterial infection) |
| | Co-trimoxazole (parenteral & oral) | (5.3 Fungal infection) |
| | Cocaine 5% / Adrenaline 1:2000 gel | (15.2 Local Anaesthesia) |
| | Cocaine 5% solution | (15.2 Local Anaesthesia) |
| | Colestyramine | (1.3 Diarrhoea) |
| | Colistimethate sodium (injection to be used via nebuliser) | (5.2 Bacterial infection) |
| | Colistimethate sodium (parenteral) | (5.2 Bacterial infection) |
| | Colistimethate sodium Dry Powder Inhaler (inhaled) | (5.2 Bacterial infection) |
| | Copper histidinate injection | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Corticorelin (Corticotrophin-releasing hormone, CRH) | (6.6 Hypothalamic and anterior pituitary hormone related disorders) |
| | Creatine monohydrate | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Crisantaspase | (8.2 Malignant disease) |
| | Cyclophosphamide (oral & parenteral) | (8.2 Malignant disease) |
| | Cyclophosphamide | (10.1 Arthritis) |
| | Cyproterone | (6.7 Sex hormone responsive conditions) |
| | Cytarabine (parenteral) | (8.2 Malignant disease) |
| | Dabrafenib with Trametinib | (8.2 Malignant disease) |
| | Dacarbazine (parenteral) | (8.2 Malignant disease) |
| | Danaparoid | (2.3 Blood clots) |
| | Dantrolene | (15.1 General Anaesthesia) |
| | Dapsone (oral) | (5.3 Fungal infection) |
| | Darbepoetin alfa | (9.1 Anaemia and some other blood disorders) |
| | Darunavir (oral) | (5.6 Viral infection) |
| | Daunorubicin (parenteral) | (8.2 Malignant disease) |
| | Deferasirox | (9.2 Iron overload) |
| | Delsym liquid | (3.4 Cough and congestion) |
| | Demeclocycline | (6.1 Antidiuretic hormone disorders) |
| | Dermovate with 40% Propylene glycol | (13.3 Inflammatory skin conditions) |
| | Desferrioxamine injection | (9.2 Iron overload) |
| | Desmopressin (oral & parenteral) (nasal spray 10micrograms/spray) | (6.1 Antidiuretic hormone disorders) |
| | Dexmedetomidine (intranasal) | (15.1 General Anaesthesia) |
| | Dexmedetomidine | (15.1 General Anaesthesia) |
| | Diamorphine nasal (Ayendi) Paediatric analgesia | (15.1 General Anaesthesia) |
| | Diamorphine | (4.5 Pain) |
| | Diazepam | (15.1 General Anaesthesia) |
| | Diazoxide | (2.4 Blood pressure conditions) |
| | Diazoxide | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Diclofenac 0.1% preservative free eye drops | (11.8 Miscellaneous ophthalmic preparation) |
| | Diclofenac injection | (15.1 General Anaesthesia) |
| | Didanosine (oral) | (5.6 Viral infection) |
| | Digoxin-specific antibody fragments | (2.1 Arrhythmias) |
| | Dinoprostone | (2.9 Patent ductus arteriosus) |
| | Dinutuximab beta (parenteral) | (8.2 Malignant disease) |
| | Dipotassium hydrogen phosphate | (9.6 Fluid and electrolyte imbalances) |
| | Dithranol in Lassar’s paste 0.1 to 2% | (13.3 Inflammatory skin conditions) |
| | Dobutamine | (2.5 Heart Failure) |
| | Docetaxel (parenteral) | (8.2 Malignant disease) |
| | Dolutegravir (oral) | (5.6 Viral infection) |
| | Dopamine | (2.5 Heart Failure) |
| | Dornase alfa | (3.3 Conditions affecting sputum viscosity) |
| | Doxapram | (3.2 Allergic conditions) |
| | Doxazosin (standard-release) | (7.1 Bladder and urinary disorders) |
| | Doxepin hydrochloride 5% cream | (13.6 Pruritis) |
| | Doxorubicin (parenteral) | (8.2 Malignant disease) |
| | Doxycycline | (5.5 Protozoal infection) |
| | Droperidol | (4.4 Nausea and labyrinth disorders) |
| | Dundee sunscreen | (13.5 Photodamage) |
| | Dupilumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Eculizumab | (9.1 Anaemia and some other blood disorders) |
| | Efavirenz (oral) | (5.6 Viral infection) |
| | Elexacaftor / Tezacaftor / Ivacaftor | (3.3 Conditions affecting sputum viscosity) |
| | Emtricitabine (oral) | (5.6 Viral infection) |
| | Enfuvirtide (parenteral) | (5.6 Viral infection) |
| | Enoxaparin | (2.3 Blood clots) |
| | Enoximone | (2.5 Heart Failure) |
| | Ephedrine hydrochloride (tablets) (unlicensed indication) | (2.4 Blood pressure conditions) |
| | Ephedrine | (2.4 Blood pressure conditions) |
| | Epirubicin (parenteral) | (8.2 Malignant disease) |
| | Epoprostenol (intravenous) | (2.4 Blood pressure conditions) |
| | Epoprostenol | (2.3 Blood clots) |
| | Ergocalciferol (parenteral) | (9.10 Vitamin deficiency) |
| | Ertapenem (parenteral) | (5.2 Bacterial infection) |
| | Erythromycin (parenteral) | (5.2 Bacterial infection) |
| | Erythromycin 0.5% eye ointment (unlicensed) | (11.3 Anti-infective eye preparation) |
| | Erythropoietin (Epoetin) beta | (9.1 Anaemia and some other blood disorders) |
| | Esmolol (intravenous) | (2.4 Blood pressure conditions) |
| | Esomeprazole (intravenous infusion) | (1.4 Disorders of gastric acid and ulceration) |
| | Etanercept (parenteral) | (13.3 Inflammatory skin conditions) |
| | Etanercept | (10.1 Arthritis) |
| | Ethambutol hydrochloride (oral) | (5.2 Bacterial infection) |
| | Ethinylestradiol | (6.7 Sex hormone responsive conditions) |
| | Etoposide (oral & parenteral) | (8.2 Malignant disease) |
| | Etravirine (oral) | (5.6 Viral infection) |
| | Evorel 25 patch | (6.7 Sex hormone responsive conditions) |
| | F3T (Trifluorothymidine) 1% eye drops (unlicensed) | (11.3 Anti-infective eye preparation) |
| | Fenfluramine | (4.1 Epilepsy and other seizure disorders) |
| | Fentanyl | (15.1 General Anaesthesia) |
| | Ferric carboxymaltose (Ferinject) | (9.1 Anaemia and some other blood disorders) |
| | Ferric derisomaltose (previously known as Monofer) | (9.1 Anaemia and some other blood disorders) |
| | Filgrastim (Zarzio) | (9.3 Neutropenia and stem cell mobilisation) |
| | Flammacerium cream | (13.2 Infections of the skin) |
| | Flecainide (intravenous) | (2.1 Arrhythmias) |
| | Fleet Phospho-soda | (1.2 Constipation and bowel cleansing) |
| | Flucloxacillin (parenteral) | (5.2 Bacterial infection) |
| | Fluconazole (parenteral) | (5.3 Fungal infection) |
| | Flucytosine (oral & parenteral) | (5.3 Fungal infection) |
| | Fludarabine (oral & parenteral) | (8.2 Malignant disease) |
| | Flumazenil | (15.1 General Anaesthesia) |
| | Flunarizine | (4.5 Pain) |
| | Fluorescein IV | (11.8 Miscellaneous ophthalmic preparation) |
| | Fluticasone MDIs | (1.4 Disorders of gastric acid and ulceration) |
| | Fluticasone | (3.1 Airways disease, obstructive) |
| | Folinic acid (oral & parenteral) | (8.2 Malignant disease) |
| | Foscarnet sodium (parenteral) | (5.6 Viral infection) |
| | Fosfomycin (oral & parenteral) | (5.2 Bacterial infection) |
| | Galsulfase | (9.7 Metabolic disorders) |
| | Gammanorm 16.5% | (14.1 Immunoglobulin Therapy) |
| | Gammaplex 5% | (14.1 Immunoglobulin Therapy) |
| | Ganciclovir (parenteral) | (5.6 Viral infection) |
| | Ganciclovir eye gel 0.15% | (11.3 Anti-infective eye preparation) |
| | Gentamicin (nebulised) | (5.2 Bacterial infection) |
| | Gentamicin (parenteral) | (5.2 Bacterial infection) |
| | Gentamicin 1.5% eye drops (unlicensed) | (11.3 Anti-infective eye preparation) |
| | Glucose (parenteral) | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Glucose infusion/injection 5%, 10%, 20%, 50% | (9.6 Fluid and electrolyte imbalances) |
| | Glycerol phenylbutyrate (Ravicti) | (9.7 Metabolic disorders) |
| | Glyceryl trinitrate intravenous infusion | (2.7 Myocardial ischaemia) |
| | Glycopyrronium | (15.1 General Anaesthesia) |
| | Golimumab | (10.1 Arthritis) |
| | Gonadorelin | (6.6 Hypothalamic and anterior pituitary hormone related disorders) |
| | Grazax | (3.2 Allergic conditions) |
| | Haem arginate infusion | (9.7 Metabolic disorders) |
| | Heparin sodium | (2.3 Blood clots) |
| | Hepatitis B immunoglobulin | (14.1 Immunoglobulin Therapy) |
| | Hexamidine eye drops (unlicensed) | (11.3 Anti-infective eye preparation) |
| | Hizentra 20% | (14.1 Immunoglobulin Therapy) |
| | Humulin R Insulin 500 units/mL (unlicensed) | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Hyaluronidase | (10.4 Soft tissue and joint disorders) |
| | Hydralazine | (2.4 Blood pressure conditions) |
| | Hydrocortisone (parenteral) | (3.1 Airways disease, obstructive) |
| | Hydrocortisone sodium phosphate 3.35mg/mL eye drops (Softacort) | (11.4 Corticosteroid and other anti-inflammatory preparations) |
| | Hydroquinone 5% / Hydrocortisone 1% / Tretinoin 0.1% cream (Pigmanorm) | (13.3 Inflammatory skin conditions) |
| | Hydroxocobalamin intramuscular (10mg/2mL) | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Hydroxycarbamide (oral) | (8.2 Malignant disease) |
| | Hydroxychloroquine | (10.1 Arthritis) |
| | Ibuprofen | (2.9 Patent ductus arteriosus) |
| | Idarubicin (oral) | (8.2 Malignant disease) |
| | Idursulfase (parenteral) | (9.7 Metabolic disorders) |
| | Ifosfamide (parenteral) | (8.2 Malignant disease) |
| | Imiglucerase (parenteral) | (9.7 Metabolic disorders) |
| | Imipenem / cilastatin (parenteral) | (5.2 Bacterial infection) |
| | Infliximab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Infliximab | (1.1 Chronic bowel disorders) |
| | Infliximab | (10.1 Arthritis) |
| | Infliximab | (10.4 Soft tissue and joint disorders) |
| | Infliximab | (4.3 Movement disorders) |
| | Interferon alfa-2a 1 million units/1mL eye drops (unlicensed) | (11.8 Miscellaneous ophthalmic preparation) |
| | Interleukin inhibitors | (10.1 Arthritis) |
| | Intralipid (lipid emulsion therapy) | (15.1 General Anaesthesia) |
| | Irinotecan hydrochloride (parenteral) | (8.2 Malignant disease) |
| | Iron dextran (CosmoFer) | (9.1 Anaemia and some other blood disorders) |
| | Iron sucrose (Venofer) | (9.1 Anaemia and some other blood disorders) |
| | Isoflurane | (15.1 General Anaesthesia) |
| | Isoniazid (oral) | (5.2 Bacterial infection) |
| | Isotretinoin capsules | (13.7 Rosacea and Acne) |
| | Itulazax (Standardised allergen extract of pollen from white birch [Betula verrucosa]) | (3.2 Allergic conditions) |
| | Ivacaftor | (3.3 Conditions affecting sputum viscosity) |
| | Ivermectin (oral) (unlicensed) | (5.4 Helminth infection) |
| | Ivermectin (oral) | (13.2 Infections of the skin) |
| | Joulies phosphate solution | (9.6 Fluid and electrolyte imbalances) |
| | Ketamine | (15.1 General Anaesthesia) |
| | Ketamine | (4.5 Pain) |
| | Ketorolac 0.5% eye drops | (11.8 Miscellaneous ophthalmic preparation) |
| | Ketorolac injection | (10.3 Pain and inflammation in musculoskeletal disorders) |
| | Ketorolac injection | (15.1 General Anaesthesia) |
| | L-ornithine | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Labetalol (intravenous) | (2.4 Blood pressure conditions) |
| | Lamivudine (oral) | (5.6 Viral infection) |
| | Lanreotide | (6.6 Hypothalamic and anterior pituitary hormone related disorders) |
| | Lanthanum | (9.6 Fluid and electrolyte imbalances) |
| | Laronidase | (9.7 Metabolic disorders) |
| | LAT (Lidocaine, Adrenaline and Tetracaine) gel | (15.2 Local Anaesthesia) |
| | Lenograstim recombinant human granulocyte-colony stimulating factor (rHuG-CSF) | (9.3 Neutropenia and stem cell mobilisation) |
| | Levamisole (oral) | (5.4 Helminth infection) |
| | Levobupivacaine 2.5mg/mL, 5mg/mL and 7.5mg/mL injection | (15.2 Local Anaesthesia) |
| | Levocarnitine | (9.7 Metabolic disorders) |
| | Levofloxacin 0.5% eye drops | (11.3 Anti-infective eye preparation) |
| | Levosimendan | (2.5 Heart Failure) |
| | Lidocaine 4% / Fluorescein 0.25% single-use eye drops | (11.7 Local anaesthetic) |
| | Lidocaine | (2.1 Arrhythmias) |
| | Linezolid (oral & parenteral) | (5.2 Bacterial infection) |
| | Liposomal amphotericin (parenteral) | (5.3 Fungal infection) |
| | Liquid paraffin eye ointment | (11.8 Miscellaneous ophthalmic preparation) |
| | Liraglutide | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Lomustine (oral) | (8.2 Malignant disease) |
| | Lorazepam | (15.1 General Anaesthesia) |
| | Lorazepam | (4.1 Epilepsy and other seizure disorders) |
| | Lumacaftor / Ivacaftor | (3.3 Conditions affecting sputum viscosity) |
| | Lumasiran | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Magnesium sulphate 50% (parenteral) | (9.6 Fluid and electrolyte imbalances) |
| | Magnesium sulphate | (2.1 Arrhythmias) |
| | Mannitol 20% infusion | (2.8 Oedema) |
| | Mecasermin | (6.6 Hypothalamic and anterior pituitary hormone related disorders) |
| | Mefloquine (oral) | (5.5 Protozoal infection) |
| | Melatonin | (4.6 Sleep disorders) |
| | Meloxicam | (10.3 Pain and inflammation in musculoskeletal disorders) |
| | Melphalan (oral & parenteral) | (8.2 Malignant disease) |
| | Mercaptamine | (11.8 Miscellaneous ophthalmic preparation) |
| | Mercaptamine | (9.7 Metabolic disorders) |
| | Mercaptopurine (oral) | (8.2 Malignant disease) |
| | Meropenem (parenteral) | (5.2 Bacterial infection) |
| | Mesna (oral & parenteral) | (8.2 Malignant disease) |
| | Metaraminol | (2.5 Heart Failure) |
| | Methotrexate (parenteral & oral) | (8.2 Malignant disease) |
| | Methylprednisolone | (10.4 Soft tissue and joint disorders) |
| | Metolazone (unlicensed) | (2.4 Blood pressure conditions) |
| | Metolazone | (2.8 Oedema) |
| | Metronidazole (parenteral) | (5.2 Bacterial infection) |
| | Metyrapone | (6.2 Corticosteroid responsive conditions) |
| | Mexiletine | (2.1 Arrhythmias) |
| | Micafungin (parenteral) | (5.3 Fungal infection) |
| | Midazolam | (15.1 General Anaesthesia) |
| | Migalastat | (9.7 Metabolic disorders) |
| | Miglustat | (9.7 Metabolic disorders) |
| | Milrinone | (2.5 Heart Failure) |
| | Mitomycin (parenteral & bladder instillation) | (8.2 Malignant disease) |
| | Mitomycin 0.02% or 0.04% eye drops (unlicensed) | (11.8 Miscellaneous ophthalmic preparation) |
| | Modafinil | (4.6 Sleep disorders) |
| | Mycophenolate (oral) | (10.1 Arthritis) |
| | Mycophenolate (oral) | (13.3 Inflammatory skin conditions) |
| | Mycophenolate mofetil (oral & parenteral) | (8.1 Immune system) |
| | Mycophenolate | (1.1 Chronic bowel disorders) |
| | Mycophenolic acid | (8.1 Immune system) |
| | Naloxone | (15.1 General Anaesthesia) |
| | Nelarabine (parenteral) | (8.2 Malignant disease) |
| | Neostigmine / Glycopyrronium | (15.1 General Anaesthesia) |
| | Neostigmine | (10.2 Neuromuscular disorders) |
| | Neostigmine | (15.1 General Anaesthesia) |
| | Nevirapine (oral) | (5.6 Viral infection) |
| | Nimodipine | (2.2 Bleeding disorders) |
| | Nitisinone | (9.7 Metabolic disorders) |
| | Nitrous oxide | (15.1 General Anaesthesia) |
| | Noradrenaline | (2.5 Heart Failure) |
| | Norethisterone | (6.7 Sex hormone responsive conditions) |
| | Normal immunoglobulins | (14.1 Immunoglobulin Therapy) |
| | Octagam 10% | (14.1 Immunoglobulin Therapy) |
| | Octreotide | (6.3 Diabetes mellitus and hypoglycaemia) |
| | Oily phenol injection 5% | (1.9 Rectal and anal disorders) |
| | Olanzapine | (4.2 Mental health disorders) |
| | Olaratumab (parenteral) | (8.2 Malignant disease) |
| | Omalizumab | (3.1 Airways disease, obstructive) |
| | Omeprazole (intravenous infusion) | (1.4 Disorders of gastric acid and ulceration) |
| | OralVac | (3.2 Allergic conditions) |
| | Orlistat | (6.9 Obesity) |
| | Oxaliplatin (parenteral) | (8.2 Malignant disease) |
| | Oxybuprocaine 0.4% single-use eye drops | (11.7 Local anaesthetic) |
| | Oxybutynin (transdermal) | (7.1 Bladder and urinary disorders) |
| | Oxycodone (PCA) | (4.5 Pain) |
| | Palforzia | (3.2 Allergic conditions) |
| | Palivizumab (parenteral) | (5.6 Viral infection) |
| | Palivizumab | (14.4 Vaccines) |
| | Palonosetron | (4.4 Nausea and labyrinth disorders) |
| | Pamidronate | (6.4 Drugs affecting bone metabolism) |
| | Pancuronium | (15.1 General Anaesthesia) |
| | Pantoprazole (intravenous infusion) | (1.4 Disorders of gastric acid and ulceration) |
| | Paracetamol injection | (15.1 General Anaesthesia) |
| | Paraldehyde | (4.1 Epilepsy and other seizure disorders) |
| | Pegfilgrastim | (9.3 Neutropenia and stem cell mobilisation) |
| | Peginterferon alfa (parenteral) | (5.6 Viral infection) |
| | Pegmivosant | (6.6 Hypothalamic and anterior pituitary hormone related disorders) |
| | Pegvisomant | (6.5 Gonadotrophin responsive conditions) |
| | Penicillamine | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Pentamidine (parenteral & nebulised) | (5.3 Fungal infection) |
| | Pethidine | (4.5 Pain) |
| | Phenobarbital (parenteral) | (4.1 Epilepsy and other seizure disorders) |
| | Phenylephrine | (2.4 Blood pressure conditions) |
| | Phenytoin (parenteral) | (4.1 Epilepsy and other seizure disorders) |
| | Phenytoin (slow intravenous injection) | (4.1 Epilepsy and other seizure disorders) |
| | PHMB (Polyhexamethylene biguanide hydrochloride) eye drops (unlicensed) | (11.3 Anti-infective eye preparation) |
| | Phosphate enema | (1.2 Constipation and bowel cleansing) |
| | Phosphate-Sandoz tablets | (9.6 Fluid and electrolyte imbalances) |
| | Phosphates polyfusor infusion | (9.6 Fluid and electrolyte imbalances) |
| | Piperacillin / Tazobactam (parenteral) | (5.2 Bacterial infection) |
| | Plasmalyte 148 and 5% glucose | (9.6 Fluid and electrolyte imbalances) |
| | Plasmalyte 148 | (9.6 Fluid and electrolyte imbalances) |
| | Plerixafor | (9.3 Neutropenia and stem cell mobilisation) |
| | Pollinex Quattro | (3.2 Allergic conditions) |
| | Polystyrene sulfonate resins | (9.6 Fluid and electrolyte imbalances) |
| | Poractant alfa (Curosurf) | (3.5 Respiratory depression, respiratory distress syndrome and apnoea) |
| | Posaconazole (oral) | (5.3 Fungal infection) |
| | Potassium ascorbate 10% eye drops (unlicensed) | (11.8 Miscellaneous ophthalmic preparation) |
| | Potassium canrenoate (intravenous) | (2.5 Heart Failure) |
| | Potassium Chloride 600mg (8mmol) modified release tablets | (9.6 Fluid and electrolyte imbalances) |
| | Potassium chloride syrup 1mmol/mL | (9.6 Fluid and electrolyte imbalances) |
| | Praziquantel (oral) (unlicensed) | (5.4 Helminth infection) |
| | Primaquine (oral) (unlicensed) | (5.3 Fungal infection) |
| | Primaquine (oral) (unlicensed) | (5.5 Protozoal infection) |
| | Privigen 10% | (14.1 Immunoglobulin Therapy) |
| | Procaine benzylpenicillin (parenteral) (unlicensed) | (5.2 Bacterial infection) |
| | Proguanil hydrochloride (oral) | (5.5 Protozoal infection) |
| | Proguanil hydrochloride / Atovaquone (oral) (Malarone) | (5.5 Protozoal infection) |
| | Propafenone (intravenous) | (2.1 Arrhythmias) |
| | Propofol 1% (10mg/mL) | (15.1 General Anaesthesia) |
| | Propofol 2% (20mg/mL) | (15.1 General Anaesthesia) |
| | Protamine | (2.3 Blood clots) |
| | Proxymetacaine 0.5% single-use eye drops | (11.7 Local anaesthetic) |
| | Pyrazinamide (oral) (unlicensed) | (5.2 Bacterial infection) |
| | Pyridostigmine | (10.2 Neuromuscular disorders) |
| | Pyridoxal 5 phosphate | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Pyrimethamine (oral) | (5.5 Protozoal infection) |
| | Pyrimethamine / Sulfadoxine (oral) (Fansidar) (unlicensed) | (5.5 Protozoal infection) |
| | Quetiapine | (4.2 Mental health disorders) |
| | Quinine (oral & parenteral) | (5.5 Protozoal infection) |
| | Rabies immunoglobulin | (14.1 Immunoglobulin Therapy) |
| | Ranibizumab | (11.8 Miscellaneous ophthalmic preparation) |
| | Rasburicase | (8.2 Malignant disease) |
| | Remdesivir | (5.7 Treatment of COVID-19) |
| | Remifentanil | (15.1 General Anaesthesia) |
| | Ribavirin (oral) | (5.6 Viral infection) |
| | Rifabutin (oral) | (5.2 Bacterial infection) |
| | Rifampicin (oral) | (5.2 Bacterial infection) |
| | Rifampicin (parenteral) | (5.2 Bacterial infection) |
| | Rilpivirine (oral) | (5.6 Viral infection) |
| | Risankizumab | (1.1 Chronic bowel disorders) |
| | Ritlecitinib | (13.8 Scalp and hair conditions) |
| | Ritonavir (oral) | (5.6 Viral infection) |
| | Rituximab (parenteral & subcutaneous) | (8.2 Malignant disease) |
| | Rituximab | (10.1 Arthritis) |
| | Rocuronium | (15.1 General Anaesthesia) |
| | Ropivacaine | (15.2 Local Anaesthesia) |
| | Sando K | (9.6 Fluid and electrolyte imbalances) |
| | Sapropterin dihydrochloride | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Sebelipase alfa | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Secukinumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Selumetinib (oral) | (8.2 Malignant disease) |
| | Sevelamer carbonate sachets | (9.6 Fluid and electrolyte imbalances) |
| | Sevelamer | (9.6 Fluid and electrolyte imbalances) |
| | Sevoflurane | (15.1 General Anaesthesia) |
| | Sildenafil (oral) | (2.4 Blood pressure conditions) |
| | Sirolimus (oral) | (8.1 Immune system) |
| | Sodium chloride 0.18% / Glucose 4% intravenous infusion | (9.6 Fluid and electrolyte imbalances) |
| | Sodium chloride 0.9% / Glucose 5% | (9.6 Fluid and electrolyte imbalances) |
| | Sodium chloride 2.7% | (9.6 Fluid and electrolyte imbalances) |
| | Sodium chloride 5% (parenteral) | (9.6 Fluid and electrolyte imbalances) |
| | Sodium chloride 5% drops | (11.8 Miscellaneous ophthalmic preparation) |
| | Sodium chloride modified-release (Slow Sodium) | (9.6 Fluid and electrolyte imbalances) |
| | Sodium dichloroacetate | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Sodium Glycerophosphate 17.9% solution | (9.6 Fluid and electrolyte imbalances) |
| | Sodium lactate intravenous infusion compound (Hartmann's solution) | (9.6 Fluid and electrolyte imbalances) |
| | Sodium nitroprusside | (2.4 Blood pressure conditions) |
| | Sodium oxybate | (4.6 Sleep disorders) |
| | Sodium phenylbutyrate | (9.7 Metabolic disorders) |
| | Sodium thiopentone | (4.1 Epilepsy and other seizure disorders) |
| | Sodium valproate injection | (4.1 Epilepsy and other seizure disorders) |
| | Somatorelin (GHRH) | (6.6 Hypothalamic and anterior pituitary hormone related disorders) |
| | Somatrogon | (6.6 Hypothalamic and anterior pituitary hormone related disorders) |
| | Somatropin (synthetic Human Growth Hormone) | (6.6 Hypothalamic and anterior pituitary hormone related disorders) |
| | Sotrovimab (Xevudy) | (5.7 Treatment of COVID-19) |
| | Sterile potassium chloride concentrate (20mmol/10mL {15%}) | (9.6 Fluid and electrolyte imbalances) |
| | Streptokinase | (2.3 Blood clots) |
| | Streptokinase | (2.7 Myocardial ischaemia) |
| | Streptomycin (parenteral) (unlicensed) | (5.2 Bacterial infection) |
| | Subcuvia 16% | (14.1 Immunoglobulin Therapy) |
| | Succinylated gelatin 40g (4%) (Gelofusine, Isoplex) | (9.6 Fluid and electrolyte imbalances) |
| | Sucralfate (oral) | (1.4 Disorders of gastric acid and ulceration) |
| | Sucralfate enema (unlicensed) | (1.4 Disorders of gastric acid and ulceration) |
| | Sucralfate liquid (oral) | (12.3 Drug acting on the oropharynx) |
| | Sugammadex | (15.1 General Anaesthesia) |
| | Sulthiame | (4.1 Epilepsy and other seizure disorders) |
| | Suxamethonium | (15.1 General Anaesthesia) |
| | TachoSil fibrin patch | (2.7 Myocardial ischaemia) |
| | Tacrolimus (oral & parenteral) | (8.1 Immune system) |
| | Tacrolimus 0.03%, 0.1% ointment (unlicensed) | (11.8 Miscellaneous ophthalmic preparation) |
| | Tacrolimus | (1.1 Chronic bowel disorders) |
| | Tadalafil (oral) | (2.4 Blood pressure conditions) |
| | Tamsulosin capsules (modified-release) | (7.1 Bladder and urinary disorders) |
| | Tapentadol (20mg/mL oral solution) | (4.5 Pain) |
| | Taurolock | (2.3 Blood clots) |
| | Teicoplanin (parenteral) | (5.2 Bacterial infection) |
| | Temocillin (parenteral) | (5.2 Bacterial infection) |
| | Tenofovir disoproxil (oral) | (5.6 Viral infection) |
| | Terlipressin | (1.7 Liver disorders and related conditions) |
| | Terlipressin | (6.1 Antidiuretic hormone disorders) |
| | Tetanus immunoglobulin | (14.1 Immunoglobulin Therapy) |
| | Tetracaine 4% gel (Ametop) | (15.2 Local Anaesthesia) |
| | Tetracosactide (ACTH) (Syncathen test) | (6.6 Hypothalamic and anterior pituitary hormone related disorders) |
| | Tetracosactide | (4.1 Epilepsy and other seizure disorders) |
| | Tezacaftor / Ivacaftor | (3.3 Conditions affecting sputum viscosity) |
| | Thiopental sodium | (15.1 General Anaesthesia) |
| | Thiopental | (4.1 Epilepsy and other seizure disorders) |
| | Thiotepa (parenteral) | (8.2 Malignant disease) |
| | Tinzaparin | (2.3 Blood clots) |
| | Tiopronin | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Tobramycin (inhaled) | (5.2 Bacterial infection) |
| | Tobramycin (nebulised) | (5.2 Bacterial infection) |
| | Tobramycin (parenteral) | (5.2 Bacterial infection) |
| | Tocilizumab | (10.1 Arthritis) |
| | Tofacitinib | (10.1 Arthritis) |
| | Tolazoline | (2.4 Blood pressure conditions) |
| | Topotecan (oral) | (8.2 Malignant disease) |
| | Treosulfan (parenteral) | (8.2 Malignant disease) |
| | Tretinoin (oral) | (8.2 Malignant disease) |
| | Triamcinolone acetonide (Kenalog) | (10.4 Soft tissue and joint disorders) |
| | Triptorelin acetate (Gonapeptyl Depot) | (6.5 Gonadotrophin responsive conditions) |
| | Triptorelin pamoate (Decapeptyl) | (6.5 Gonadotrophin responsive conditions) |
| | Ulipristal acetate (Esmya) | (7.3 Contraception) |
| | Upadacitinib (oral) | (13.3 Inflammatory skin conditions) |
| | Urokinase | (2.3 Blood clots) |
| | Ustekinumab (parenteral) | (13.3 Inflammatory skin conditions) |
| | Ustekinumab | (1.1 Chronic bowel disorders) |
| | Ustekinumab | (10.1 Arthritis) |
| | Valaciclovir (oral) | (5.6 Viral infection) |
| | Valganciclovir (oral) | (5.6 Viral infection) |
| | Valganciclovir solution (oral) | (5.6 Viral infection) |
| | Vancomycin (parenteral) | (5.2 Bacterial infection) |
| | Vancomycin 1.4% eye drops (unlicensed - Special) | (11.3 Anti-infective eye preparation) |
| | Vancomycin 5% eye drops (unlicensed) | (11.3 Anti-infective eye preparation) |
| | Varicella-Zoster immunoglobulin | (14.1 Immunoglobulin Therapy) |
| | Vasopressin | (1.7 Liver disorders and related conditions) |
| | Vasopressin | (6.1 Antidiuretic hormone disorders) |
| | Vecuronium | (15.1 General Anaesthesia) |
| | Velmanase alfa | (9.7 Metabolic disorders (continued 9.7.13 Onwards)) |
| | Veraseal | (17.1 Miscellaneous Preparations) |
| | Vigabatrin | (4.1 Epilepsy and other seizure disorders) |
| | Vinblastine (parenteral) | (8.2 Malignant disease) |
| | Vincristine (parenteral) | (8.2 Malignant disease) |
| | Vindesine (parenteral) | (8.2 Malignant disease) |
| | Vinorelbine (parenteral) | (8.2 Malignant disease) |
| | Voriconazole (oral & parenteral) | (5.3 Fungal infection) |
| | Voriconazole 1% eye drops (unlicensed Special) | (11.3 Anti-infective eye preparation) |
| | Zanamivir (intravenous) | (5.6 Viral infection) |
| | Zidovudine (oral & parenteral) | (5.6 Viral infection) |